Incidence of leukopenia after intraperitonealvscombined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei | Zendy

Philipp Horvath | Zendy; Stefan Beckert | Zendy; Florian Struller | Zendy; Alfred Königsrainer | Zendy; Ingmar Königsrainer | Zendy

Open Access

Incidence of leukopenia after intraperitonealvscombined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei

Author(s) -

Philipp Horvath,

Stefan Beckert,

Florian Struller,

Alfred Königsrainer,

Ingmar Königsrainer

Publication year - 2016

Publication title -

world journal of gastrointestinal pharmacology and therapeutics

Language(s) - English

Resource type - Journals

ISSN - 2150-5349

DOI - 10.4292/wjgpt.v7.i3.434

Subject(s) - leukopenia , medicine , surgery , pseudomyxoma peritonei , incidence (geometry) , mitomycin c , oxaliplatin , hyperthermic intraperitoneal chemotherapy , gastroenterology , chemotherapy , cancer , colorectal cancer , appendix , ovarian cancer , cytoreductive surgery , paleontology , physics , optics , biology

To investigate the clinical impact of post-hyperthermic intraperitoneal chemotherapy (HIPEC) leukopenia, intraperitoneal and combined intravenous/intraperitoneal drug administrations were compared.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research